{"entity":{"type":"insider","cik":"0001629381","url":"/insider/0001629381","json_url":"/insider/0001629381.json","name":"Crowley Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":24,"first":"2015-03-12","last":"2025-03-18","span_basis":"filed_date"},"name_variants":[{"name":"Crowley Michael","source":"filing","n_filings":24,"first_seen":"2015-03-12","last_seen":"2025-03-18"}],"transactions":[{"id":4664296,"accession":"0001062993-25-005730","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-25-005730","line_url":"/filing/0001062993-25-005730#line-2","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIO.B","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":247.0614,"price_display":"247.06","price_state":"stated","total_value":741184.2,"total_display":"741,184.20","total_whole":"741,184","shares_owned_after":8171.0,"shares_owned_after_display":"8,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-14","filed_date":"2025-03-18","scope":"insider"},{"id":3038455,"accession":"0001062993-24-012628","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-24-012628","line_url":"/filing/0001062993-24-012628#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":369.0,"shares_display":"369","price_per_share":281.9064,"price_display":"281.91","price_state":"stated","total_value":104023.4616,"total_display":"104,023.46","total_whole":"104,023","shares_owned_after":6573.0,"shares_owned_after_display":"6,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-13","filed_date":"2024-06-14","scope":"insider"},{"id":2396527,"accession":"0001062993-24-004835","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-24-004835","line_url":"/filing/0001062993-24-004835#line-2","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":336.0,"price_display":"336.00","price_state":"stated","total_value":1008000.0,"total_display":"1,008,000.00","total_whole":"1,008,000","shares_owned_after":6942.0,"shares_owned_after_display":"6,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-27","filed_date":"2024-02-28","scope":"insider"},{"id":8402437,"accession":"0001062993-23-021535","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-23-021535","line_url":"/filing/0001062993-23-021535#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":642.0,"shares_display":"642","price_per_share":305.1,"price_display":"305.10","price_state":"stated","total_value":195874.2,"total_display":"195,874.20","total_whole":"195,874","shares_owned_after":6942.0,"shares_owned_after_display":"6,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-28","filed_date":"2023-11-28","scope":"insider"},{"id":8751275,"accession":"0001062993-23-013732","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-23-013732","line_url":"/filing/0001062993-23-013732#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":500.0,"shares_display":"500","price_per_share":379.39,"price_display":"379.39","price_state":"stated","total_value":189695.0,"total_display":"189,695.00","total_whole":"189,695","shares_owned_after":6040.0,"shares_owned_after_display":"6,040","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-15","filed_date":"2023-06-16","scope":"insider"},{"id":4099663,"accession":"0001062993-21-007240","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-21-007240","line_url":"/filing/0001062993-21-007240","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":754.9318666666667,"price_display":"754.93","price_state":"stated","total_value":2264795.6,"total_display":"2,264,795.60","total_whole":"2,264,796","shares_owned_after":4099.0,"shares_owned_after_display":"4,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-09","filed_date":"2021-08-10","scope":"insider","n_lines":2},{"id":3282910,"accession":"0001062993-20-006420","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-20-006420","line_url":"/filing/0001062993-20-006420#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":374.0,"shares_display":"374","price_per_share":580.67,"price_display":"580.67","price_state":"stated","total_value":217170.58,"total_display":"217,170.58","total_whole":"217,171","shares_owned_after":3669.0,"shares_owned_after_display":"3,669","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-15","filed_date":"2020-12-17","scope":"insider"},{"id":3343765,"accession":"0001812865-20-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001812865-20-000002","line_url":"/filing/0001812865-20-000002#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":485.4,"price_display":"485.40","price_state":"stated","total_value":728100.0,"total_display":"728,100.00","total_whole":"728,100","shares_owned_after":2310.0,"shares_owned_after_display":"2,310","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-01","filed_date":"2020-06-02","scope":"insider"},{"id":8432591,"accession":"0001652252-19-000020","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001652252-19-000020","line_url":"/filing/0001652252-19-000020#line-3","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1089.0,"shares_display":"1,089","price_per_share":333.0788,"price_display":"333.08","price_state":"stated","total_value":362722.8132,"total_display":"362,722.81","total_whole":"362,723","shares_owned_after":2011.0,"shares_owned_after_display":"2,011","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-04","filed_date":"2019-09-05","scope":"insider"},{"id":8603980,"accession":"0001315406-19-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001315406-19-000010","line_url":"/filing/0001315406-19-000010#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":325.0,"shares_display":"325","price_per_share":320.0,"price_display":"320.00","price_state":"stated","total_value":104000.0,"total_display":"104,000.00","total_whole":"104,000","shares_owned_after":3100.0,"shares_owned_after_display":"3,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-14","filed_date":"2019-08-14","scope":"insider"},{"id":6563480,"accession":"0001315406-18-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001315406-18-000011","line_url":"/filing/0001315406-18-000011#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO-RAD LABORATORIES, INC.","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":392.0,"shares_display":"392","price_per_share":248.0297,"price_display":"248.03","price_state":"stated","total_value":97227.6424,"total_display":"97,227.64","total_whole":"97,228","shares_owned_after":3425.0,"shares_owned_after_display":"3,425","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-14","filed_date":"2018-12-14","scope":"insider"},{"id":6241999,"accession":"0001315406-18-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001315406-18-000008","line_url":"/filing/0001315406-18-000008#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":350.0,"shares_display":"350","price_per_share":303.4204,"price_display":"303.42","price_state":"stated","total_value":106197.14,"total_display":"106,197.14","total_whole":"106,197","shares_owned_after":2142.0,"shares_owned_after_display":"2,142","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-13","filed_date":"2018-06-14","scope":"insider"},{"id":4503695,"accession":"0001315406-17-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001315406-17-000018","line_url":"/filing/0001315406-17-000018#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":258.3947,"price_display":"258.39","price_state":"stated","total_value":258394.7,"total_display":"258,394.70","total_whole":"258,395","shares_owned_after":2492.0,"shares_owned_after_display":"2,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-04","filed_date":"2017-12-04","scope":"insider"},{"id":4289394,"accession":"0001315406-17-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001315406-17-000016","line_url":"/filing/0001315406-17-000016#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":215.9088,"price_display":"215.91","price_state":"stated","total_value":151136.16,"total_display":"151,136.16","total_whole":"151,136","shares_owned_after":2060.0,"shares_owned_after_display":"2,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-11","filed_date":"2017-08-11","scope":"insider"},{"id":5232146,"accession":"0001652252-17-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001652252-17-000008","line_url":"/filing/0001652252-17-000008#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":196.1343,"price_display":"196.13","price_state":"stated","total_value":58840.29,"total_display":"58,840.29","total_whole":"58,840","shares_owned_after":2760.0,"shares_owned_after_display":"2,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-07","filed_date":"2017-03-08","scope":"insider"},{"id":2226328,"accession":"0001652252-16-000126","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001652252-16-000126","line_url":"/filing/0001652252-16-000126#line-2","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88.0,"shares_display":"88","price_per_share":165.62,"price_display":"165.62","price_state":"stated","total_value":14574.56,"total_display":"14,574.56","total_whole":"14,575","shares_owned_after":3060.0,"shares_owned_after_display":"3,060","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-07","filed_date":"2016-11-08","scope":"insider"},{"id":2973339,"accession":"0001652252-16-000114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001652252-16-000114","line_url":"/filing/0001652252-16-000114#line-2","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":127.0,"shares_display":"127","price_per_share":158.09,"price_display":"158.09","price_state":"stated","total_value":20077.43,"total_display":"20,077.43","total_whole":"20,077","shares_owned_after":2917.0,"shares_owned_after_display":"2,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-13","filed_date":"2016-09-14","scope":"insider"},{"id":2344805,"accession":"0001652252-16-000095","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001652252-16-000095","line_url":"/filing/0001652252-16-000095#line-3","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":523.0,"shares_display":"523","price_per_share":155.0195,"price_display":"155.02","price_state":"stated","total_value":81075.1985,"total_display":"81,075.20","total_whole":"81,075","shares_owned_after":2710.0,"shares_owned_after_display":"2,710","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-12","filed_date":"2016-09-13","scope":"insider"},{"id":3189075,"accession":"0001315406-16-000038","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001315406-16-000038","line_url":"/filing/0001315406-16-000038#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":669.0,"shares_display":"669","price_per_share":153.0,"price_display":"153.00","price_state":"stated","total_value":102357.0,"total_display":"102,357.00","total_whole":"102,357","shares_owned_after":1868.0,"shares_owned_after_display":"1,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-18","filed_date":"2016-08-18","scope":"insider"},{"id":8549780,"accession":"0001315406-15-000025","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001315406-15-000025","line_url":"/filing/0001315406-15-000025#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":549.0,"shares_display":"549","price_per_share":136.16,"price_display":"136.16","price_state":"stated","total_value":74751.84,"total_display":"74,751.84","total_whole":"74,752","shares_owned_after":2537.0,"shares_owned_after_display":"2,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-13","filed_date":"2015-11-16","scope":"insider"},{"id":8195524,"accession":"0001652252-15-000039","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001652252-15-000039","line_url":"/filing/0001652252-15-000039#line-3","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":270.0,"shares_display":"270","price_per_share":139.11,"price_display":"139.11","price_state":"stated","total_value":37559.7,"total_display":"37,559.70","total_whole":"37,560","shares_owned_after":2942.0,"shares_owned_after_display":"2,942","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-14","filed_date":"2015-09-15","scope":"insider"},{"id":8343825,"accession":"0001652252-15-000019","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001652252-15-000019","line_url":"/filing/0001652252-15-000019#line-2","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":152.0,"shares_display":"152","price_per_share":137.5,"price_display":"137.50","price_state":"stated","total_value":20900.0,"total_display":"20,900.00","total_whole":"20,900","shares_owned_after":2502.0,"shares_owned_after_display":"2,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-11","filed_date":"2015-09-14","scope":"insider"},{"id":8110119,"accession":"0001652252-15-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001652252-15-000006","line_url":"/filing/0001652252-15-000006#line-2","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations)","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":97.0,"shares_display":"97","price_per_share":139.01,"price_display":"139.01","price_state":"stated","total_value":13483.97,"total_display":"13,483.97","total_whole":"13,484","shares_owned_after":2265.0,"shares_owned_after_display":"2,265","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-09","filed_date":"2015-09-10","scope":"insider"},{"id":8729322,"accession":"0001315406-15-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001315406-15-000008","line_url":"/filing/0001315406-15-000008#line-1","is_derivative":false,"issuer_cik":"0000012208","issuer_name":"BIO RAD LABORATORIES INC","issuer_ticker":"BIOBIOB","issuer_name_source":null,"issuer_url":"/issuer/0000012208","owner_cik":"0001629381","owner_name":"Crowley Michael","owner_display_name":"Crowley Michael","owner_url":"/insider/0001629381","role":"Officer (EVP, GBL Commercial Operations), Ten percent owner","role_mark":"O","role_mark_label":"Officer (EVP, GBL Commercial Operations)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, GBL Commercial Operations","security_title":"Bio-Rad A Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":134.05,"price_display":"134.05","price_state":"stated","total_value":26810.0,"total_display":"26,810.00","total_whole":"26,810","shares_owned_after":2112.0,"shares_owned_after_display":"2,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-03-10","filed_date":"2015-03-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000012208","name":"BIO-RAD LABORATORIES, INC.","url":"/issuer/0000012208","role":"Officer (EVP, GBL Commercial Operations), Ten percent owner","n_filings":24,"first_seen":"2015-03-12","last_seen":"2025-03-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001629381","retrieved_at":"2026-08-23T14:00:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}